Cancer Epigenetics & Oncology

    Epigenetic modifications of the Cancer cell genome, which does not bring a change in the nucleotide sequence, is called Cancer Epigenetics.

 

     Cancer was the first human disease to be linked to epigenetics.  DNA hypomethylation can activate oncogenes and initiate chromosome instability, whereas DNA hypermethylationinitiates silencing of tumor suppressor genes. An accumulation of epigenetic & genetic errors can transform a normal cell into an invasive or metastatic tumor cell. DNA methylation patterns may cause abnormal expression of cancer-associated genes. Global histone modification patterns are also found to correlate with cancers such as breast, prostate, and pancreatic cancer.

      Epigenetic modification are as important as genetic mutations in a cell's transformation to cancer, and their manipulation holds great promise for cancer prevention, detection, and therapy.

     During the cell transformation to a cancerous cell, Epigenetic modifications are also crucial like genetic mutations. Their modification brings a great promising approach for prevention, detection, and therapy of Cancer.

 

  • Novel epigenetics targets in cancer
  • Histone variants and histone modifications
  • Cancer stem cells
  • Epigenetic tools and technologies
  • Epigenetic & Genetic aspects of breast cancer progression
  • Breast cancer risk and prevention

Related Conference of Cancer Epigenetics & Oncology

March 15-15, 2021

Genetics and Molecular biology

Paris, France
September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia

Cancer Epigenetics & Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in